Author

D. Kanojia

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Organism:human· 2 Approach:statistical model· 2 Assay:ATAC-seq· 1 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Assay:ChIP-seq· 1 Research Focus:chromatin & epigenetic regulation· 1

Frequent Co-Authors

M. Zannikou· 2 shared A. M. Orriols· 1 shared A. Mayakonda· 1 shared A. Vassilopoulos· 1 shared C. Yau· 1 shared C. Yeh· 1 shared C.-Q. Li· 1 shared D. Horiuchi· 1 shared

Activity by Year

2019-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 19 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

M. Zannikou

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

S100A8/A9 predicts triple-negative breast cancer response to PIM kinase and PD-1/PD-L1 inhibition

L. R. Begg, A. M. Orriols, M. Zannikou, C. Yeh, P. Vadlamani, D. Kanojia, R. Bolin, S. F. Dunne, S. Balakrishnan, R. Camarda, D. Roth, N. A. Zielinski-Mozny, C. Yau, A. Vassilopoulos, T.-H. Huang, , D. Horiuchi

bioRxiv · Sep 21, 2023 · PreprintCancer Biology

Low Level Whole-Brain Radiation Enhances Theranostic Potential Of Single Domain Antibody Fragments For HER2-Positive Brain Metastases

D. Procissi, S. Jannetti, M. Zannikou, Z. Zhou, D. McDougald, D. Kanojia, G. Vaidyanathan, M. R. Zalutsky, I. V. Balyasnikova

This study shows that low-dose whole-brain irradiation increases the uptake of an anti-HER2 VHH in intracranial tumors, enhancing its theranostic potential for HER2-positive brain metastases.

bioRxiv · Apr 19, 2022Cancer Biology

TP63, SOX2 and KLF5 Establish Core Regulatory Circuitry and Construct Cancer Specific Epigenome in Esophageal Squamous Cell Carcinoma

Y. Jiang, Y. Jiang, C.-Q. Li, Z. Ying, P. Dakle, J.-W. Deng, R. Y.-T. Lin, H. Kaur, L. Han, J.-J. Xie, A. Mayakonda, M. Hazawa, L. Xu, Y. Li, L. Aswad, , H. P. Koeffler

This study identifies TP63, SOX2, and KLF5 as core regulatory circuitry transcription factors in ESCC that drive epigenetic modifications and tumor growth through super-enhancer interactions.

bioRxiv · Nov 6, 2019 · PreprintCancer Biology